A smart watch for respiratory disease patients launched by Aseptika monitors the oxygen levels in patients’ blood.

It is aimed at people suffering from Chronic Obstructive Pulmonary Disease (COPD), the collective name for a group of conditions that includes chronic bronchitis, emphysema and chronic obstructive airways disease.

“Our BuddyWOTCH will become an integrated monitoring and alerting system, wearable for the ‘rest-of-life’ by the most vulnerable patients with respiratory disease,” said Kevin Auton, Aseptika’s founder and managing director.

Get the full story at www.cambridge-news.co.uk